Northern Institute for Cancer Research

Staff Profile

Dr Alastair Greystoke

Clinical Senior Lecturer/Hon Consultant

Background

Dr Greystoke joined Newcastle University and the Northern Centre for Cancer Care in 2014 after 8 years spent at the University of Manchester/ Christie NHS Trust.  He is one of 3 consultants that run the Sir Bobby Robson Early Clinical Trials Centre at the Freeman hospital in Newcastle, and has a special interest in the development of new anti-cancer drugs for patients with lung cancer. He is a member of Lung CSG, leads systemic therapy research for NSCLC in the North-East, with a portfolio of Phase I-IV studies, and is the sub-specialty lead for lung cancer for the North-East England and North Cumbria NIHR CRN. In addition he is the Principle Investigator of PROSPECT-NE a study assessing molecular profiles in patients referred for early clinical studies in Newcastle and he leads the Pharmacodynamic Biomarker team at the Northern Institute for Cancer Research, Newcastle University.


Areas of expertise

  • Lung Cancer
  • Early Drug development
  • Personalised Medicine
  • Circulating Biomarkers
  • Treatment of cancer in the elderly


Twitteralastair.greyst2

Google Scholar: Click here.

Publications